A.Y. Chen, A. Jemal, E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16), 3801–3807 (2009). https://doi.org/10.1002/cncr.24416
R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer Statistics, 2021. CA Cancer J. Clin. 71(1), 7–33 (2021). https://doi.org/10.3322/caac.21654
X. Shi, R. Liu, F. Basolo, R. Giannini, X. Shen, D. Teng, H. Guan, Z. Shan, W. Teng, T.J. Musholt, K. Al-Kuraya, L. Fugazzola, C. Colombo, E. Kebebew, B. Jarzab, A. Czarniecka, B. Bendlova, V. Sykorova, M. Sobrinho-Simões, P. Soares, Y.K. Shong, T.Y. Kim, S. Cheng, S.L. Asa, D. Viola, R. Elisei, L. Yip, C. Mian, F. Vianello, Y. Wang, S. Zhao, G. Oler, J.M. Cerutti, E. Puxeddu, S. Qu, Q. Wei, H. Xu, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, A.K. Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Yu, G. Tallini, E.H. Holt, V. Vasko, M. Xing, Differential clinicopathological risk and prognosis of major papillary thyroid cancer subtypes. J. Clin. Endocrinol Metab 101(1), 264–274 (2016). https://doi.org/10.1210/jc.2015-2917.
Article CAS PubMed Google Scholar
L.Y. Wang, F.L. Palmer, I.J. Nixon, D. Thomas, S.G. Patel, A.R. Shaha, J.P. Shah, R.M. Tuttle, I. Ganly, Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer. Thyroid 24(Nov 11), 1594–1599 (2014). https://doi.org/10.1089/thy.2014.0173
Article CAS PubMed Google Scholar
U. Khan, A. Al Afif, A. Aldaihani, C. MacKay, M.H. Rigby, M. Rajaraman, S.A. Imran, M.J. Bullock, S.M. Taylor, J.R.B. Trites, R.D. Hart, Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study. J Otolaryngol Head Neck Surg 49(1), 78 (2020). https://doi.org/10.1186/s40463-020-00469-8
Article PubMed PubMed Central Google Scholar
H.G. Vuong, U.N.P. Duong, T.Q. Pham, H.M. Tran, N. Oishi, K. Mochizuki, T. Nakazawa, L. Hassell, R. Katoh, T. Kondo, Clinicopathological risk factors for distant metastasis in differentiated thyroid carcinoma: A meta-analysis. World J. Surg. 42(4), 1005–1017 (2018). https://doi.org/10.1007/s00268-017-4206-1
P. Goffredo, J.A. Sosa, S.A. Roman, Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades. World J. Surg. 37(7), 1599–1605 (2013). https://doi.org/10.1007/s00268-013-2006-9
Z. Al-Qurayshi, C.B. Sullivan, N. Pagedar, G.S. Lee, R. Tufano, E. Kandil, Prevalence and risk of metastatic thyroid cancers and management outcomes: A national perspective. Laryngoscope 131(1), 237–244 (2021). https://doi.org/10.1002/lary.28722
A.S. Alzahrani, D. Alkhafaji, M. Tuli, H. Al-Hindi, B.B. Sadiq, Comparison of differentiated thyroid cancer in children and adolescents (≤20 years) with young adults. Clin Endocrinol (Oxf) 84(4), 571–577 (2016). https://doi.org/10.1111/cen.12845
K. Sugino, M. Nagahama, W. Kitagawa, K. Ohkuwa, T. Uruno, K. Matsuzu, A. Suzuki, C. Tomoda, K.Y. Hames, J. Akaishi, C. Masaki, K. Ito, Distant metastasis in pediatric and adolescent differentiated thyroid cancer: Clinical outcomes and risk factor analyses. J. Clin. Endocrinol. Metab. 105(11), dgaa545 (2020). https://doi.org/10.1210/clinem/dgaa545
X. Zeng, Z. Wang, Z. Gui, J. Xiang, M. Cao, W. Sun, L. He, W. Dong, J. Huang, D. Zhang, C. Lv, T. Zhang, L. Shao, P. Zhang, H. Zhang, High incidence of distant metastasis is associated with histopathological subtype of pediatric papillary thyroid cancer—a Retrospective Analysis Based on SEER. Front Endocrinol (Lausanne) 12(Nov), 760901 (2021). https://doi.org/10.3389/fendo.2021.760901
F. Basolo, E. Macerola, A.M. Poma, L. Torregrossa, The 5th edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma. Endocrine 80(3), 470–476 (2023). https://doi.org/10.1007/s12020-023-03336-4
Article CAS PubMed PubMed Central Google Scholar
M.B. Amin, S.B. Edge, F.L. Greene. AJCC Cancer Staging Manual. 8th ed. Springer, Chicago, IL), 2017)
A.P. Hardin, J.M. Hackell, COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE. Age Limit of Pediatrics. Pediatrics 140(3), e20172151 (2017). https://doi.org/10.1542/peds.2017-2151
D. Ylli, K.D. Burman, D. Van Nostrand, L. Wartofsky, Eliminating the age cutoff in staging of differentiated thyroid cancer: The safest road? J. Clin. Endocrinol. Metab. 103(5), 1813–1817 (2018). https://doi.org/10.1210/jc.2017-02725
S. Yamashita, V. Saenko, Mechanisms of Disease: molecular genetics of childhood thyroid cancers. Nat. Clin. Pract. Endocrinol Metab. 3(5), 422–429 (2007). https://doi.org/10.1038/ncpendmet0499
Article CAS PubMed Google Scholar
F. Vaisman, R. Corbo, M. Vaisman, Thyroid carcinoma in children and adolescents-systematic review of the literature. J. Thyroid Res. 2011, 845362 (2011). https://doi.org/10.4061/2011/845362.
Article PubMed PubMed Central Google Scholar
A. Patel, S. Jhiang, S. Dogra, R. Terrell, P.A. Powers, C. Fenton, C.A. Dinauer, R.M. Tuttle, G.L. Francis, Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatr Res. 52(5), 737–744 (2002). https://doi.org/10.1203/00006450-200211000-00021
Article CAS PubMed Google Scholar
J.J. Min, J.K. Chung, Y. Lee, J. Jeong, D. Lee, J. Jang, M. Lee, B. Cho, Relationship between expression of the sodium/iodide symporter and (131) I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur. J. Nucl. Med. 28(5), 639–645 (2001). https://doi.org/10.1007/s002590100509
留言 (0)